Spots Global Cancer Trial Database for 5fluorouracil
Every month we try and update this database with for 5fluorouracil cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Induction Therapy With Panitumumab + mFOLFOX-6 in Rectal Cancer and Quadruple Wild-type Mutation Before Surgery | NCT03000374 | Rectal Cancer | Panitumumab 5Fluorouracil Oxaliplatin Leucovorin | 18 Years - 74 Years | Grupo Espanol Multidisciplinario del Cancer Digestivo | |
| Irinotecan, 5-Fluorouracil and Leucovorin With or Without Iressa in the Treatment of Metastatic Colorectal Cancer | NCT00233623 | Metastatic Colo... | Iressa (Gefitin... Irinotecan 5Fluorouracil Leucovorin | 18 Years - | AstraZeneca | |
| Pegliposomal Doxorubicin and 5-fluorouracil as Second Line Therapy for Metastatic Gastric Cancer | NCT04358341 | Gastric Cancer | Irinotecan DOXOrubicin Lip... 5fluorouracil | 18 Years - 70 Years | Sixth Affiliated Hospital, Sun Yat-sen University | |
| Using Positron Emission Tomography to Evaluate the Effects of Bevacizumab on Intra-tumoral Pharmacokinetics of 5-fluorouracil in Metastatic Colorectal Cancer | NCT00165568 | Colorectal Canc... Neoplasm Metast... | Bevacizumab | 18 Years - | Dana-Farber Cancer Institute | |
| Rollover Study to Provide Continued Access to Napabucasin for Patients Enrolled in Boston Biomedical-sponsored Protocols | NCT04299880 | Oncology | Napabucasin Nab-paclitaxel Gemcitabine Nivolumab Paclitaxel Irinotecan Leucovorin 5Fluorouracil Bevacizumab | 18 Years - | Sumitomo Pharma America, Inc. | |
| AVELUMAB and CETUXIMAB and mFOLFOXIRI as Initial Therapy for Unresectable Metastatic Colorectal Cancer Patients | NCT04513951 | Metastatic Colo... | 5Fluorouracil L-leucovorin Irinotecan Oxaliplatin Cetuximab Avelumab | 18 Years - 75 Years | Gruppo Oncologico del Nord-Ovest | |
| QUILT-2.024: Phase 2 Neoadjuvant, Consolidation, and Adjuvant Combination NANT Immunotherapy Versus Standard of Care in Subjects With Resectable Non-small Cell Lung Cancer | NCT03574649 | Non Small Cell ... | Nab-paclitaxel Cisplatin 5Fluorouracil Cyclophosphamid... ETBX-011 ETBX-051 ETBX-061 GI-4000 GI-6301 Aldoxorubicin Avelumab ALT-803 haNK Docetaxel carboplatin | 18 Years - | ImmunityBio, Inc. | |
| Rollover Study to Provide Continued Access to Napabucasin for Patients Enrolled in Boston Biomedical-sponsored Protocols | NCT04299880 | Oncology | Napabucasin Nab-paclitaxel Gemcitabine Nivolumab Paclitaxel Irinotecan Leucovorin 5Fluorouracil Bevacizumab | 18 Years - | Sumitomo Pharma America, Inc. | |
| Study of Neoadjuvant Nivolumab or Placebo Plus Chemotherapy Followed by Surgery and Adjuvant Treatment in Subjects With Resectable ESCC | NCT05213312 | Esophageal Squa... | Nivolumab Cisplatin Paclitaxel 5Fluorouracil Esophagectomy (... | 18 Years - 75 Years | Shanghai Zhongshan Hospital | |
| 5FU/LV, Irinotecan, Temozolomide and Bevacizumab for MGMT Silenced, Microsatellite Stable Metastatic Colorectal Cancer. | NCT04689347 | Metastatic Colo... | Bevacizumab Irinotecan Leucovorin 5Fluorouracil Temozolomide | 18 Years - 75 Years | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | |
| ATATcH Alternating Treatment Plans for Advanced Cancer | NCT05358548 | Head and Neck C... Lung Cancer | Paclitaxel Pemetrexed 5Fluorouracil Carboplatin Pembrolizumab | 18 Years - | Rutgers, The State University of New Jersey | |
| Study of Ociperlimab (BGB-A1217) in Combination With Tislelizumab in Advanced Solid Tumors | NCT04047862 | Locally Advance... | Ociperlimab Tislelizumab Pemetrexed Paclitaxel Nab paclitaxel Carboplatin Cisplatin Etoposide 5fluorouracil Oxaliplatin Capecitabine | 18 Years - | BeiGene | |
| Rollover Study to Provide Continued Access to Napabucasin for Patients Enrolled in Boston Biomedical-sponsored Protocols | NCT04299880 | Oncology | Napabucasin Nab-paclitaxel Gemcitabine Nivolumab Paclitaxel Irinotecan Leucovorin 5Fluorouracil Bevacizumab | 18 Years - | Sumitomo Pharma America, Inc. | |
| Home Parenteral Nutrition for Malnourished Unresectable Stage IV Gastric Cancer | NCT03121807 | Metastatic Gast... | Oliclinomel N4 ... Oxaliplatin 5Fluorouracil Leucovorin | 20 Years - 80 Years | Kaohsiung Medical University Chung-Ho Memorial Hospital | |
| An Adaptive-design Prospective Cohort Study of Watch and Wait Strategy in Patients With Locally Advanced Rectal Cancer | NCT04443543 | Rectal Cancer | Capecitabine (X... irinotecan IMRT Oxaliplatin 5Fluorouracil Tislelizumab | 18 Years - 75 Years | Fudan University | |
| Gene and Protein Expression Profiles After Treatment of Actinic Keratoses | NCT05740969 | Actinic Keratos... | 5Fluorouracil Imiquimod Melatonin | 18 Years - | Zealand University Hospital | |
| Induction Therapy With Panitumumab + mFOLFOX-6 in Rectal Cancer and Quadruple Wild-type Mutation Before Surgery | NCT03000374 | Rectal Cancer | Panitumumab 5Fluorouracil Oxaliplatin Leucovorin | 18 Years - 74 Years | Grupo Espanol Multidisciplinario del Cancer Digestivo | |
| Study of Ociperlimab (BGB-A1217) in Combination With Tislelizumab in Advanced Solid Tumors | NCT04047862 | Locally Advance... | Ociperlimab Tislelizumab Pemetrexed Paclitaxel Nab paclitaxel Carboplatin Cisplatin Etoposide 5fluorouracil Oxaliplatin Capecitabine | 18 Years - | BeiGene | |
| Surgical Excision Versus Photodynamic Therapy and Topical 5-fluorouracil in Treatment of Bowen's Disease | NCT03909646 | Bowen's Disease | Methyl Aminolev... 5Fluorouracil Surgical excisi... | 18 Years - | Maastricht University Medical Center | |
| Study to Assess the Efficacy and Safety of Treatment With FOLFIRI-aflibercept Compared to Initial Treatment With FOLFIRI-aflibercept (for 6 Cycles) Followed by Maintenance With 5FU-aflibercept, in an Elderly Population With mCRC After Failure of an Oxaliplatin-based Regimen | NCT03279289 | Metastatic Colo... | Aflibercept Irinotecan folinic acid (d... 5Fluorouracil 5-FU | 70 Years - | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) | |
| AVELUMAB and CETUXIMAB and mFOLFOXIRI as Initial Therapy for Unresectable Metastatic Colorectal Cancer Patients | NCT04513951 | Metastatic Colo... | 5Fluorouracil L-leucovorin Irinotecan Oxaliplatin Cetuximab Avelumab | 18 Years - 75 Years | Gruppo Oncologico del Nord-Ovest | |
| Capecitabine Versus Bolus 5-Fu Associated to Radiotherapy as Neoadjuvant Treatment for Rectal Cancer. | NCT03428529 | Rectal Neoplasm... | Capecitabine Or... 5Fluorouracil | 18 Years - 80 Years | Instituto Nacional de Cancer, Brazil | |
| Capecitabine Versus Bolus 5-Fu Associated to Radiotherapy as Neoadjuvant Treatment for Rectal Cancer. | NCT03428529 | Rectal Neoplasm... | Capecitabine Or... 5Fluorouracil | 18 Years - 80 Years | Instituto Nacional de Cancer, Brazil | |
| A Study to Assess the Effectiveness and Safety of Irinotecan Liposome Injection, 5-fluorouracil/Leucovorin Plus Oxaliplatin in Patients Not Previously Treated for Metastatic Pancreatic Cancer, Compared to Nab-paclitaxel+Gemcitabine Treatment | NCT04083235 | Metastatic Aden... | Irinotecan Lipo... Oxaliplatin 5Fluorouracil Leucovorin Nab-paclitaxel Gemcitabine | 18 Years - | Ipsen | |
| A Trial to Compare Oxaliplatin, Folinic Acid (FA) and 5-Fluorouracil (5FU) Combination Chemotherapy (FOLFOX-4) With or Without Cetuximab in the 1st Line Treatment of Metastatic Colorectal Cancer (mCRC) in Chinese Rat Sarcoma Viral Oncogene Homolog (RAS) Wild-type Patients | NCT01228734 | Metastatic Colo... | Cetuximab Oxaliplatin Folinic Acid 5Fluorouracil | 18 Years - | Merck KGaA, Darmstadt, Germany | |
| Paediatric Hepatic International Tumour Trial | NCT03017326 | Hepatoblastoma Carcinoma, Hepa... | Cisplatin Doxorubicin Carboplatin 5Fluorouracil Vincristine Etoposide Irinotecan Gemcitabine Oxaliplatin Sorafenib | - 30 Years | University of Birmingham | |
| A Study to Assess the Effectiveness and Safety of Irinotecan Liposome Injection, 5-fluorouracil/Leucovorin Plus Oxaliplatin in Patients Not Previously Treated for Metastatic Pancreatic Cancer, Compared to Nab-paclitaxel+Gemcitabine Treatment | NCT04083235 | Metastatic Aden... | Irinotecan Lipo... Oxaliplatin 5Fluorouracil Leucovorin Nab-paclitaxel Gemcitabine | 18 Years - | Ipsen | |
| QUILT-2.024: Phase 2 Neoadjuvant, Consolidation, and Adjuvant Combination NANT Immunotherapy Versus Standard of Care in Subjects With Resectable Non-small Cell Lung Cancer | NCT03574649 | Non Small Cell ... | Nab-paclitaxel Cisplatin 5Fluorouracil Cyclophosphamid... ETBX-011 ETBX-051 ETBX-061 GI-4000 GI-6301 Aldoxorubicin Avelumab ALT-803 haNK Docetaxel carboplatin | 18 Years - | ImmunityBio, Inc. | |
| Capecitabine Versus Bolus 5-Fu Associated to Radiotherapy as Neoadjuvant Treatment for Rectal Cancer. | NCT03428529 | Rectal Neoplasm... | Capecitabine Or... 5Fluorouracil | 18 Years - 80 Years | Instituto Nacional de Cancer, Brazil | |
| Study to Assess the Efficacy and Safety of Treatment With FOLFIRI-aflibercept Compared to Initial Treatment With FOLFIRI-aflibercept (for 6 Cycles) Followed by Maintenance With 5FU-aflibercept, in an Elderly Population With mCRC After Failure of an Oxaliplatin-based Regimen | NCT03279289 | Metastatic Colo... | Aflibercept Irinotecan folinic acid (d... 5Fluorouracil 5-FU | 70 Years - | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
